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Pertussis Treatment and Chemoprophylaxis table link 
We regret that in last week’s Friday update, what was meant to be a table for pertussis 
treatment and chemoprophylaxis ended up being somewhat unreadable when it was sent 
over the list serve.  Please go to the following link: pertussis treatment and 
chemoprophylaxis table for a good copy of this table. 
Interpretation of Hepatitis B Laboratory Profiles: an overview for local public 
health and other health care providers 
IDPH will review every lab result for Hepatitis B (HBV) before sending out the disease 
report.  Only in those cases where an acute infection is suspected will results be sent to 
local public health agency for follow-up.  
  
The following information is intended to help clarify test results when conducting a 
disease investigation.  Since several tests for HBV are used to determine susceptibility to 
HBV infection—vaccine-induced immunity and acute or chronic infection—
interpretation is often difficult.  It may be helpful to review results with the person’s 
physician when attempting to determine acute or chronic status. 
Routine Tests 
•       Hepatitis B Surface Antigen (HBsAg): A serologic marker on the surface of 
HBV. It can be detected in high levels in serum during acute or chronic hepatitis. The 
presence of HBsAg indicates that the person is infectious.  HBsAg refers to the outer 
surface of the hepatitis B virus that usually triggers an antibody response. It appears 1- 10 
weeks after exposure to the virus, and if HBsAg persists after six months, it signals a 
chronic hepatitis B infection. 
•       Hepatitis B Surface Antibody (anti-HBs): The presence of anti-HBs is 
generally interpreted as indicating recovery and immunity from HBV infection. Anti-HBs 
also develop in a person who has been successfully vaccinated against hepatitis B. This is 
sometimes written as HbsAb.  
•       Total Hepatitis B Core Antibody (anti-HBc): Appears after the onset of 
symptoms in acute hepatitis B and persists for life. The presence of anti-HBc indicates 
previous or ongoing infection with hepatitis B virus (HBV) in an undefined time frame.  
The appearance of anti-HBc with the protective antibodies (HBsAb+ or anti-HBs+) 
indicates recovery from an infection. In chronically infected persons, it will appear with 
the antigen (HBsAg). 
•       IgM Antibody to Hepatitis B Core Antigen (IgM anti-HBc): This antibody 
appears during acute or recent HBV infection and is present for about 6 months after 
initial infection.   This antibody will eventually decrease and marker will eventually be 
replaced with IgG anti-HBc. 
Additional Tests 
•       IgG Anti-HBc (Hepatitis B core antibody IgG): Indicates past or present 
infection with HBV.  Its presence with surface antibodies (HBsAb or anti-HBs) indicates 
prior infection and recovery. If present with viral antigen (HBsAg), this indicates a 
chronic infection.  
•       HBeAg (Hepatitis B e-Antigen): Associated with chronic infections and is 
used as a marker of active viral disease and indicates that a patient is more likely to 
spread the disease.  
•       HBeAb or anti-HBe (Antibody to Hepatitis B e-antigen): Detected in patients 
who have recovered from hepatitis B infections as well as those who are chronically 
infected. This antibody appears weeks to months after HBeAg is no longer detectable in 
the blood. If this test result is "positive" in a person with chronic hepatitis B, then it 
indicates reduced viral replication (or inactive liver disease) thus less infectiousness and 
signals complete e-antigen seroconversion.  
•       HBV DNA (Hepatitis B viral DNA): A marker to detect the amount of virus in 
the bloodstream and is used to diagnose active hepatitis B viral disease. Testing requires 
very sensitive and expensive PCR methods. Results are usually quantified in terms of 
picograms/ml or copies/ml.  Not typically used to diagnose acute HBV cases.  
Serology interpretation tables are available from CDC and the Hepatitis B 
Foundation.   
For more information on viral hepatitis, visit the Iowa Department of Public Health 
Hepatitis Program Website 
Tips for safe and healthy travel 
Although traveling abroad is usually a wonderful and enjoyable experience, 
approximately 50percent of international travelers get sick or injured (hurt) during their 
trip.  As a result it is always wise to do some research and get thorough information on 
your countries of destination before your trip.  Click on the following “top travel tips” 
from the CDC, to find out what you can do prevent most travel-related sickness and 
injury:    
•       Wash your hands frequently with soap and water or an alcohol-based hand rub, 
especially before eating.  
•       Drink only boiled or bottled water or carbonated drinks from sources you trust. 
Avoid tap water, fountain drinks, and ice cubes.  
•       Eat only fully cooked food or fruits and vegetables you have peeled. 
Remember: boil it, cook it, peel it, or forget it! 
•       If visiting an area where there is risk for malaria, take malaria prevention 
medication before, during, and after your trip, as appropriate. Check the font color here. 
•       If you are likely to be bitten by insects (like mosquitoes or ticks) use insect 
repellent with an approved insect repellent ingredient.  For more information on mosquito 
repellents go to mosquito repellent fact sheet. 
•       Know how to prevent injuries during your trip.  
Additional information and other travel tips are available at: 
http://www.cdc.gov/travel/other/traveltips.htm 
Please note- The Fall EPI Update date change for region one: 
The date for the Fall EPI Update at Iowa Valley Continuing Education Center, 
Marshalltown, IA has been changed to Oct. 25,  2005.  
Meetings: 
Link to 8th Annual HIV/AIDS Conference to be held Oct. 11, 2005, through Oct. 12, 
2005  
http://www.trainingresources.HIV/AIDS Conference Link 
 
